These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Suades R; Padró T; Vilahur G; Badimon L Thromb Haemost; 2012 Dec; 108(6):1208-19. PubMed ID: 23138460 [TBL] [Abstract][Full Text] [Related]
69. Platelet-derived chemokines in vascular remodeling and atherosclerosis. Koenen RR; Weber C Semin Thromb Hemost; 2010 Mar; 36(2):163-9. PubMed ID: 20414831 [TBL] [Abstract][Full Text] [Related]
70. Fractalkine--a local inflammatory marker aggravating platelet activation at the vulnerable plaque. Flierl U; Schäfer A Thromb Haemost; 2012 Sep; 108(3):457-63. PubMed ID: 22739755 [TBL] [Abstract][Full Text] [Related]
71. The arterial microenvironment: the where and why of atherosclerosis. Yurdagul A; Finney AC; Woolard MD; Orr AW Biochem J; 2016 May; 473(10):1281-95. PubMed ID: 27208212 [TBL] [Abstract][Full Text] [Related]
72. Platelets are a previously unrecognised source of MIF. Strüßmann T; Tillmann S; Wirtz T; Bucala R; von Hundelshausen P; Bernhagen J Thromb Haemost; 2013 Nov; 110(5):1004-13. PubMed ID: 23846621 [TBL] [Abstract][Full Text] [Related]
73. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Jennings LK Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875 [TBL] [Abstract][Full Text] [Related]
74. Platelet interactions as therapeutic targets for prevention of atherothrombosis. Smid J; Braun-Dullaeus R; Gawaz M; Langer HF Future Cardiol; 2009 May; 5(3):285-96. PubMed ID: 19450054 [TBL] [Abstract][Full Text] [Related]